Show simple item record

dc.contributor.authorPrice, David B.
dc.contributor.authorRussell, Richard
dc.contributor.authorMares, Rafael
dc.contributor.authorBurden, Anne
dc.contributor.authorSkinner, Derek
dc.contributor.authorMikkelsen, Helga
dc.contributor.authorDing, Cherlyn
dc.contributor.authorBrice, Richard
dc.contributor.authorChavannes, Niels H.
dc.contributor.authorKocks, Janwillem W. H.
dc.contributor.authorStephens, Jeffrey W.
dc.contributor.authorHaughney, John
dc.date.accessioned2016-10-03T12:00:07Z
dc.date.available2016-10-03T12:00:07Z
dc.date.issued2016-09-22
dc.identifier.citationPrice , D B , Russell , R , Mares , R , Burden , A , Skinner , D , Mikkelsen , H , Ding , C , Brice , R , Chavannes , N H , Kocks , J W H , Stephens , J W & Haughney , J 2016 , ' Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes : A Historical Matched Cohort Study ' , PloS ONE , vol. 11 , no. 9 , e0162903 , pp. 1-17 . https://doi.org/10.1371/journal.pone.0162903en
dc.identifier.issn1932-6203
dc.identifier.otherPURE: 71318839
dc.identifier.otherPURE UUID: affe7644-da38-48f3-abbe-ea10af78569f
dc.identifier.otherPubMed: 27658209
dc.identifier.otherScopus: 84992093427
dc.identifier.urihttp://hdl.handle.net/2164/7563
dc.descriptionFunding: The analyses were funded by Boehringer Ingelheim. Access to data from the Optimum Patient Care Research Database was co-funded by Research in Real Life Ltd. The funder, Boehringer Ingelheim, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rafael Mares is employed by Research in Real Life Ltd., which provided support in the form of salary for author RM but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the ‘author contributions’ section. Acknowledgments The authors wish to thank Vicky Thomas, Elizabeth Gardener, Rosie McDonald, Simon Yau and J.B. Soriano for critical reading of the manuscript. Our thanks also go to other colleagues at Research in Real Life Ltd. for valuable discussions.en
dc.format.extent17
dc.language.isoeng
dc.relation.ispartofPloS ONEen
dc.rightsCopyright: © 2016 Price et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. https://creativecommons.org/licenses/by/4.0/en
dc.subjectR Medicineen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccRen
dc.titleMetabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes : A Historical Matched Cohort Studyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1371/journal.pone.0162903


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record